These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9075715)

  • 1. Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels.
    Lundeen SG; Carver JM; McKean ML; Winneker RC
    Endocrinology; 1997 Apr; 138(4):1552-8. PubMed ID: 9075715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study.
    Shughrue PJ; Lane MV; Merchenthaler I
    Endocrinology; 1997 Dec; 138(12):5476-84. PubMed ID: 9389534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
    Black LJ; Sato M; Rowley ER; Magee DE; Bekele A; Williams DC; Cullinan GJ; Bendele R; Kauffman RF; Bensch WR
    J Clin Invest; 1994 Jan; 93(1):63-9. PubMed ID: 8282823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
    Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
    Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    Sato M; Rippy MK; Bryant HU
    FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of raloxifene in immature and ovariectomized rat uterotrophic assays.
    Ashby J; Odum J; Foster JR
    Regul Toxicol Pharmacol; 1997 Jun; 25(3):226-31. PubMed ID: 9237325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain.
    Cyr M; Thibault C; Morissette M; Landry M; Di Paolo T
    Neuropsychopharmacology; 2001 Aug; 25(2):242-57. PubMed ID: 11425508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
    Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
    Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal activity of combinations of genistein, bisphenol A and 17beta-estradiol in the female Wistar rat.
    Schmidt S; Degen GH; Seibel J; Hertrampf T; Vollmer G; Diel P
    Arch Toxicol; 2006 Dec; 80(12):839-45. PubMed ID: 16639590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
    Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
    Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.
    Unkila M; Kari S; Yatkin E; Lammintausta R
    J Steroid Biochem Mol Biol; 2013 Nov; 138():107-15. PubMed ID: 23665515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens.
    Branham WS; Zehr DR; Sheehan DM
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):297-303. PubMed ID: 8516342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
    Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and tamoxifen modulate cerebrovascular tone in ovariectomized female rats.
    Tsang SY; Yao X; Chan FL; Wong CM; Chen ZY; Laher I; Huang Y
    Hypertension; 2004 Jul; 44(1):78-82. PubMed ID: 15159380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
    Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD
    Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
    J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone.
    Willson TM; Norris JD; Wagner BL; Asplin I; Baer P; Brown HR; Jones SA; Henke B; Sauls H; Wolfe S; Morris DC; McDonnell DP
    Endocrinology; 1997 Sep; 138(9):3901-11. PubMed ID: 9275080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.